Egalet Corporation

Description

• Egalet, a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet has three approved products: ARYMO ER (morphine sulfate) extended-release tablets for oral use only CII, developed using Egalets proprietary Guardian Technology, OXAYDO® (oxycodone HCI, USP) tablets for oral use only CII and SPRIX® (ketorolac tromethamine) Nasal Spray. Using Guardian Technology Egalet is developing a pipeline of clinical-stage, product candidates including Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Guardian Technology can be applied broadly across different classes of pharmaceutical products and can be used to develop combination products that include multiple active pharmaceutical ingredients with similar or different release profiles. For full prescribing information on ARYMO ER, including the boxed warning and medication guide, please visit arymoer.com. For full prescribing information on SPRIX, including the boxed warning and medication guide, please visit sprix.com. For full prescribing information on OXAYDO, including the boxed warning, please visit oxaydo.com. For additional information on Egalet, please visit egalet.com.
• 

  Headquarters:600 Lee Road Suite 100, Wayne, Pennsylvania, United States

  More
• 

  Phone Number: +1 610-833-4200

• 

  Website: https://www.egalet.com

• 

  Employees:110

• 

  Revenue:$10 - 50M

• 

  Legal Name:Egalet Corporation

• Egalet Corporation's Social Media

  
• Is this data correct?

• |  NAICS Code: 325412  |

  Show More